Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT03637803 |
| Title | MRx0518 and Pembrolizumab Combination Study |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | 4DPharma PLC |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | United States | Details | |
| UPMC Hillman Cancer Center | Pittsburgh | Pennsylvania | 15232 | United States | Details | |
| Houston Methodist Cancer Center | Houston | Texas | 77030 | United States | Details | |
| MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
| Summit Cancer Center | Spokane | Washington | 99208 | United States | Details |